Successful treatment of massive pulmonary embolism with low-dose tissue plasminogen activator after meniscus surgery


ZENCİRKIRAN AĞUŞ H., UYGUR B., Guler A., Demirci G., KALKAN A. K., YILDIZ M.

Blood Coagulation and Fibrinolysis, cilt.29, sa.6, ss.559-561, 2018 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 29 Sayı: 6
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1097/mbc.0000000000000754
  • Dergi Adı: Blood Coagulation and Fibrinolysis
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.559-561
  • Anahtar Kelimeler: massive pulmonary embolism, postoperative period, tissue plasminogen activator
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Pulmonary embolism is a life-threatening disease which represents with high mortality and morbidity. Systemic fibrinolysis is the first-line recommended therapy in hemodynamically instable patients with massive pulmonary embolism. Systemic fibrinolytic treatment remains controversial for pulmonary embolism after surgery due to high risk of hemorrhage. Herein, we report a 49-year-old man with massive pulmonary embolism after meniscus surgery, successfully treated with low-dose prolonged infusion of tissue type plasminogen activator. Blood Coagul Fibrinolysis 29:559-561.